About Breslin

Thirty years of considered advice.

Breslin was founded in Zurich in 1996. The firm advises on private equity secondaries, corporate finance and strategic transactions, and invests selectively as a principal. Its distinguishing trait has been constant from the beginning: scientific fluency applied to financial decisions.

Origins

Founded in 1996 with a focus on biotechnology and life sciences, Breslin became one of the early European practitioners of private equity secondary transactions.

Mandate

To give clients advice that is defensible, discreet and grounded in evidence, and to stand behind it through execution.

Method

Small senior teams. Direct partner involvement in every mandate. Processes designed around the asset rather than around a template.

 

History

Three decades, in brief.

  1. 1996

    Founding

    Breslin is established in Zurich to support innovation and growth in biotechnology and life sciences.

  2. 2004

    Early secondaries practice

    The firm becomes one of the early European practitioners of secondary private equity transactions across life sciences, industrials and non cyclicals.

  3. 2009

    Corporate finance

    Advisory capabilities broaden into fundraising, M&A and structured financing.

  4. 2014

    Wider advisory bench

    The advisory team expands, adding sector expertise across more verticals.

  5. 2016

    Direct investing

    Breslin begins investing directly in early and growth stage companies, taking an active role through critical development phases.

  6. Today

    International practice

    Breslin serves institutional investors and corporates from Zurich, London and San Francisco, with mandates across Europe, the UK and the US.

 

Leadership

A senior bench, personally engaged.

The firm is led by its founder and a management team whose careers span Bayer, Dresdner Kleinwort, Commerzbank and ETH Zurich, supported by an advisory bench across Zurich, Lausanne, Munich, Düsseldorf and San Francisco. Doctorates in biochemistry, chemistry, immunology and molecular genetics sit alongside decades of banking and board experience.

Meet the team

 

Get to know the firm before you need it.

Relationships here tend to begin well ahead of a transaction. We are glad to talk early.

Scroll to Top